Mai-Britt Zocca - 23 Dec 2024 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca
Issuer symbol
IOBT
Transactions as of
23 Dec 2024
Net transactions value
+$10,120
Form type
4
Filing time
23 Dec 2024, 18:56:14 UTC
Previous filing
18 Mar 2024
Next filing
04 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOBT Common Stock Purchase $10,120 +12,500 +33% $0.8096 49,891 23 Dec 2024 Direct F1
holding IOBT Common Stock 26,580 23 Dec 2024 Zocca Consulting ApS F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The actual purchase price is $0.809556 per share of Common Stock, which has been rounded due to systematic character limitations.
F2 The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of her pecuniary interest therein.